ATE316779T1 - Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung - Google Patents

Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung

Info

Publication number
ATE316779T1
ATE316779T1 AT98930779T AT98930779T ATE316779T1 AT E316779 T1 ATE316779 T1 AT E316779T1 AT 98930779 T AT98930779 T AT 98930779T AT 98930779 T AT98930779 T AT 98930779T AT E316779 T1 ATE316779 T1 AT E316779T1
Authority
AT
Austria
Prior art keywords
production
controlled release
implants
core
active ingredients
Prior art date
Application number
AT98930779T
Other languages
English (en)
Inventor
Alexandra Rothen-Weinhold
Robert Gurny
Piero Orsolini
Frederic Heimgartner
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Application granted granted Critical
Publication of ATE316779T1 publication Critical patent/ATE316779T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT98930779T 1997-06-04 1998-06-02 Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung ATE316779T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9706874 1997-06-04

Publications (1)

Publication Number Publication Date
ATE316779T1 true ATE316779T1 (de) 2006-02-15

Family

ID=9507573

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930779T ATE316779T1 (de) 1997-06-04 1998-06-02 Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung

Country Status (10)

Country Link
US (1) US6319512B1 (de)
EP (1) EP1001743B1 (de)
JP (1) JP2002511075A (de)
AT (1) ATE316779T1 (de)
AU (1) AU742372B2 (de)
CA (1) CA2291659A1 (de)
DE (1) DE69833375D1 (de)
IL (1) IL133105A (de)
NO (1) NO995908L (de)
WO (1) WO1998055101A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767550B1 (en) * 2000-06-30 2004-07-27 Berkeley Advanced Biomaterials, Inc. Hydroxyapatite based drug delivery implant for cancer treatment
US20040115236A1 (en) * 2000-10-06 2004-06-17 Chan Tai Wah Devices and methods for management of inflammation
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
CA2451187C (en) 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
CN1289064C (zh) * 2001-08-31 2006-12-13 先灵有限责任公司 药物输送体系
DE10237572A1 (de) 2002-08-13 2004-02-26 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Stent mit polymerer Beschichtung
SE0202619D0 (sv) * 2002-09-05 2002-09-05 Fredrik Nederberg New Polymers and Applications
KR101242486B1 (ko) * 2004-01-12 2013-03-13 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 장기 전달을 위한 제형 및 그의 이용 방법
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8119154B2 (en) * 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
WO2005107715A1 (en) * 2004-05-11 2005-11-17 Debio Recherche Pharmaceutique S.A. Implantable composition
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
JP5405825B2 (ja) * 2005-07-18 2014-02-05 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 薬剤含有インプラント及びその使用方法
KR20130024988A (ko) * 2005-12-22 2013-03-08 노파르티스 아게 옥트레오티드 및 ２종 이상의 폴리락티드-코-글리콜리드 중합체를 포함하는 서방형 제제
KR101446813B1 (ko) * 2006-04-06 2014-10-01 뉴파쎄 인크. 도파민 연관된 상태의 치료를 위한 이식체
AU2007248949B2 (en) * 2006-05-09 2010-04-08 Astrazeneca Ab Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
ITMI20061538A1 (it) * 2006-08-02 2008-02-03 Mediolanum Pharmaceuticals Ltd Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
EP2222281B1 (de) 2007-12-20 2018-12-05 Evonik Corporation Verfahren zur herstellung von mikropartikeln mit geringer restlösemittelmenge
WO2010088697A2 (en) * 2009-02-02 2010-08-05 Medtronic, Inc. Antimicrobial accessory for an implantable medical device
EP2246063A1 (de) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. GnRH Analoge enthaltende Retardformulierungen
US8858983B2 (en) * 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
WO2011015958A2 (en) 2009-08-06 2011-02-10 Koninklijke Philips Electronics N.V. Oncology therapies employing radioactive seeds
CA2774495C (en) * 2009-09-17 2017-09-26 Evonik Degussa Corporation Implant devices that differ by release profile and methods of making and using same
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
US12403291B2 (en) 2019-08-30 2025-09-02 Intersect Ent, Inc. Submucosal bioresorbable drug eluting platform

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
US5011692A (en) * 1985-12-28 1991-04-30 Sumitomo Pharmaceuticals Company, Limited Sustained pulsewise release pharmaceutical preparation
US4894231A (en) 1987-07-28 1990-01-16 Biomeasure, Inc. Therapeutic agent delivery system
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
ES2052369T3 (es) * 1990-01-30 1994-07-01 Akzo Nv Articulo para el suministro controlado de una sustancia activa, que comprende un espacio hueco completamente cerrado por una pared y lleno en su totalidad o en parte con una o mas sustancias activas.
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
CA2141459A1 (en) * 1992-07-31 1994-02-17 Richard Yu Controlled release implants
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
DE69720190T2 (de) * 1996-02-02 2003-12-11 Alza Corp Implantierbares system mit verzögerter freisetzung von leuprolid

Also Published As

Publication number Publication date
US6319512B1 (en) 2001-11-20
AU742372B2 (en) 2002-01-03
DE69833375D1 (de) 2006-04-13
CA2291659A1 (fr) 1998-12-10
NO995908D0 (no) 1999-12-02
WO1998055101A1 (fr) 1998-12-10
AU8109398A (en) 1998-12-21
IL133105A0 (en) 2001-03-19
EP1001743A1 (de) 2000-05-24
EP1001743B1 (de) 2006-02-01
NO995908L (no) 1999-12-02
JP2002511075A (ja) 2002-04-09
IL133105A (en) 2004-09-27

Similar Documents

Publication Publication Date Title
DE69833375D1 (de) Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung
DE59610355D1 (de) Medizinisches implantat
ATE234124T1 (de) Verfahren zur herstellung von wirkstoffhaltigen knochenzementen
CA2158638A1 (en) A Composition and a Method for Tissue Augmentation
CA2235919A1 (en) Non-polymeric sustained release delivery system
NO303425B1 (no) FremgangsmÕte for behandling av et kirurgisk metallimplantat
DE69520036D1 (de) Verfahren zur herstellung von festen pharmazeutischen dosierungsformen hydrophobischen substanzen
ATE243720T1 (de) Hydrogelbildende, selbst-solvatisierende, absorbierbare polyestercopolymere sowie verfahren zu deren verwendung
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
HUP0302630A2 (hu) Eljárás gyógyszerek sterilizálására
JPH08508655A (ja) 診療および外科学に使用し得る半合成材料
NO995843D0 (no) Farmasöytisk preparat omfattende vWF-propeptid
DE3682811D1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
DE69719930D1 (de) Verfahren zur Herstellung von medizinischen Pflastern zur perkutanen Verabreichung, und Vorrichtung dafür
RU94013093A (ru) Способ хирургического лечения аневризм восходящей аорты
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
AP9801416A0 (en) Method Of treating a plant disease.
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
DK0704219T3 (da) Anvendelse af faktor for osteoblastisk celledeling
FR2736548B1 (fr) Utilisation d'un retinoide pour la preparation d'un medicament antibacterien et methode de traitement cosmetique

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties